Time to PSA Nadir and the Risk of Death from Prostate Cancer following Radiation and Androgen Deprivation Therapy

Documenti analoghi

• Duration of the anti-androgen in men undergoing six months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death
  di: Sanford, Nina N., et al.
  Pubblicazione: (2016)
• Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
  di: Lior Z. Braunstein, et al.
  Pubblicazione: (2014-01-01)
• Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
  di: Braunstein, Lior Z., et al.
  Pubblicazione: (2014)
• Early Versus Delayed Initiation Of Salvage Androgen Deprivation Therapy And Risk Of Prostate Cancer–Specific Mortality
  di: Mahal, Brandon A., et al.
  Pubblicazione: (2018)
• Time to PSA nadir independently predicts overall survival in metastatic hormone sensitive prostate cancer patients treated with androgen deprivation therapy
  di: Choueiri, Toni K., et al.
  Pubblicazione: (2009)